For over a year, DrugRisk has tracked safety concerns over the popular anticoagulant drug Pradaxa. Numerous health agencies have warned that the medication can cause internal bleeding problems at a greater rate than traditional blood thinners like warfarin.
So far, the maker of the drug, Boehringer Ingelheim, and the industry-dominated FDA, have maintained the position that Pradaxa is as safe or safer than warfarin. However, the hard numbers suggest otherwise. Pradaxa lawsuits over internal bleeding continue to grow at an alarming rate.
Pradaxa was released inn 2010 as an alternative for patients with atrial fibrillation to prevent strokes. It gained popularity since it didn’t require regular blood tests like warfarin.
However, records of complaints to the FDA quickly suggested internal bleeding injuries from Pradaxa may be dangerously high.
For the past two years, Pradaxa has been listed among the most dangerous drugs on the market, based on injury and death reports submitted to the FDA.
The Institute for Safe Medication Practices warned this year that patients taking Pradaxa could have five times the risk of death from internal bleeding than those taking warfarin. A Dutch study also found that patients taking new style blood thinners like Pradaxa could have a 55% higher chance of having internal bleeding.
Despite this, the FDA has advised Pradaxa is no more dangerous than warfarin. The maker of the drug, Boehringer Ingelheim, also claims it is safe, and has even asked that it be approved for more uses.
As word spread of Pradaxa dangers, those affected have flocked to seek help from the company that sold a defective product without warning. A special federal court was even created to handle just Pradaxa lawsuits.
Now, court records again show the number of claims has risen for the month. According to the Judicial Panel on Multidistrict Litigation, 1,748 patients have filed a Pradaxa lawsuit, up more than 6% in the past month.
Lawyers believe the number of lawsuits over Pradaxa bleeding will continue to grow as long as the drug remains on the market or until the FDA issues a Pradaxa recall. The maker could also negotiate a settlement that will compensate those injured.
If you or a loved one suffered internal bleeding from Pradaxa, help is available. Lawyers are available to discuss your case and file a claim at no cost unless you receive an award.
However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Pradaxa lawsuits.
Contact us today for more information on the research, side effects and litigation news related to Pradaxa, or to speak with a lawyer.